Drug packaging – the major diversities between Europe and America to know
Packaging must match a list of aims, such as: conserve the product, prevent stealing, be cheap, and maintain a balance among its efficacy and its cost, both from the viewpoint of the material employed and the time involved to produce the packing.
From an eco-friendly viewpoint, it is vital that materials are effortlessly recycled and used as small as possible.
There are numerous products in the retail that may be mixed up between one other due to similar aspects, colors or logos. Medicine packages should vary considerably from sanitation and cooking products. For instance, American tablet packaging confounds a drug with a food, and that is not a good idea… for the purchaser. Packaging for human medications is one of the important fields of design and research. So it would be good to take into consideration that, in this matter, there are obvious contrasts between Europe and the United States. Although health care in the United States is a topic of privates and insurance economic matters, in the majority of countries in Europe it is governmental. This diversity affects the manner in which medications are perceived by the public. Thus, American pharmacies sell a wide choice of medicines with a graphic pattern that in Europe is characteristic of more or less nutritional supplements.
On the other hand, in Europe, where the promoting of medicines is much more severe, the tablet packaging has a more practical look, with no applause and no suggestions. The justification for this difference in marketing communications is simple: the package’s destination in the EU are doctors, while in the most of the US, the target of the package is the patient.
